NCT04514796 Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Two Formulations of SB5 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT04404517 Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks Status UNKNOWN Phase PHASE3
NCT04230213 A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT04222920 Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease Activity Status COMPLETED Phase PHASE4
NCT04194827 Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring Status RECRUITING Phase PHASE4
NCT04183608 A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab Status RECRUITING Phase PHASE4
NCT04132388 Hidradenitis Suppurativa Patient Experience With Humira Treatment Status WITHDRAWN Phase PHASE4
NCT04131504 Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION) Status COMPLETED Phase N/A
NCT04115748 Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy Status TERMINATED Phase PHASE3
NCT04088409 A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04009668 Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease Status COMPLETED Phase PHASE2
NCT03983876 PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI) Status COMPLETED Phase PHASE1
NCT03927352 The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis Status UNKNOWN Phase PHASE3
NCT03895203 A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT03849404 Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3